These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36448195)

  • 1. Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype.
    Kenney-Jung DL; Rogers DJ; Kroening SJ; Zatkalik AL; Whitmarsh AE; Roberts AE; Zenker M; Gambardella ML; Contaldo I; Leoni C; Onesimo R; Zampino G; Tartaglia M; Battaglia DI; Pierpont EI
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):501-509. PubMed ID: 36448195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine.
    Snyder HE; Jain P; RamachandranNair R; Jones KC; Whitney R
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.
    Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A
    Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional vitamin B12 deficiency-associated Infantile epileptic spasms syndrome: Clinico-neurophysiological presentation, response to treatment, and neurodevelopmental outcome.
    Sharawat IK; Ramachandran A; Elwadhi A; Tomar A; Panda PK
    Seizure; 2023 Aug; 110():93-98. PubMed ID: 37331199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical Parvalbumin-Positive Interneuron Development and Function Are Altered in the APC Conditional Knockout Mouse Model of Infantile and Epileptic Spasms Syndrome.
    Ryner RF; Derera ID; Armbruster M; Kansara A; Sommer ME; Pirone A; Noubary F; Jacob M; Dulla CG
    J Neurosci; 2023 Feb; 43(8):1422-1440. PubMed ID: 36717229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India.
    Nagarajan B; Gowda VK; Yoganathan S; Sharawat IK; Srivastava K; Vora N; Badheka R; Danda S; Kalane U; Kaur A; Madaan P; Mehta S; Negi S; Panda PK; Rajadhyaksha S; Saini AG; Saini L; Shah S; Srinivasan VM; Suthar R; Thomas M; Vyas S; Sankhyan N; Sahu JK
    Epilepsia Open; 2023 Dec; 8(4):1383-1404. PubMed ID: 37583270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study.
    Pierpont EI; Kenney-Jung DL; Shanley R; Zatkalik AL; Whitmarsh AE; Kroening SJ; Roberts AE; Zenker M
    Genet Med; 2022 Jul; 24(7):1556-1566. PubMed ID: 35524774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
    Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
    Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models?
    Ng AC; Choudhary A; Barrett KT; Gavrilovici C; Scantlebury MH
    Epilepsia; 2024 Feb; 65(2):266-280. PubMed ID: 38036453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
    Prezioso G; Chiarelli F; Matricardi S
    Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Societal costs of illness for infantile epileptic spasms syndrome and evolutionary cost prediction in the era of WHO's IGAP.
    Bharti SK; Gupta I; Akshima ; Madaan P; Devi N; Dhir P; Negi S; Sankhyan N; Sahu JK; Bansal D
    Epilepsy Res; 2024 Jan; 199():107284. PubMed ID: 38159425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and outcome of infantile spasms in Denmark in 1996-2019.
    Winther CCH; Klein-Petersen AW; Preel M; Kofoed IR; Bo Nissen I; Axelgaard S; Green J; Miranda MJ; Hoei-Hansen CE
    Seizure; 2024 Jul; 120():173-179. PubMed ID: 39029407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel copy number variations and phenotypes of infantile epileptic spasms syndrome.
    Cheng M; Bai L; Yang Y; Liu W; Niu X; Chen Y; Tan Q; Yang X; Wu Q; Zhao HQ; Zhang Y
    Clin Genet; 2024 Aug; 106(2):161-179. PubMed ID: 38544467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors influencing the efficacy of initial adrenocorticotropic hormone therapy for infantile epileptic spasms syndrome].
    Huang X; Peng J; Pan Z; Peng P; He F; Zhang CL; Chen C; Liu FY; Yin F; Mao LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):60-66. PubMed ID: 36655665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genotypes and phenotypes of IQSEC2 gene variants related epilepsy].
    Wang DH; Niu XY; Cheng MM; Chen Y; Yang Y; Yang XL; Yang ZX; Zhang YH
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1317-1321. PubMed ID: 36444437
    [No Abstract]   [Full Text] [Related]  

  • 17. Hospital readmissions in children with new-onset infantile epileptic spasms syndrome.
    Harini C; Yuskaitis CJ; Singh A; McHugh T; Liu S; DeLeo M; Gupta N; Marti C; Zhang B; Libenson MH; Berry JG
    Epilepsia Open; 2023 Jun; 8(2):444-455. PubMed ID: 36790214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brazilian experts' consensus on the treatment of infantile epileptic spasm syndrome in infants.
    Sampaio LPB; Henriques-Souza AMM; Silveira MRMD; Seguti L; Santos MLSF; Montenegro MA; Antoniuk S; Manreza MLG
    Arq Neuropsiquiatr; 2023 Sep; 81(9):844-856. PubMed ID: 37793406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying risk factors for adverse events of pyridoxal phosphate in infantile epileptic spasms syndrome.
    Arai Y; Okanishi T; Kanai S; Ohta K; Sunada H; Noma H; Maegaki Y
    Epilepsy Behav; 2023 Aug; 145():109348. PubMed ID: 37459718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical mechanisms in pathogenesis of infantile epileptic spasm syndrome.
    Riikonen R
    Seizure; 2023 Feb; 105():1-9. PubMed ID: 36634586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.